Table IV.

Change From Baseline (SD) in Mean Sitting Systolic Blood Pressure/Mean Sitting Diastolic Blood Pressure (mm Hg) at the End of Study 1 in Black and White Patients*

Black Patients
Amlodipine Dose, mg	Valsartan Dose, mg
	0	40	80	160	320
0	+0.9 (15.5)/–1.2 (8.0)	–8.6 (16.6)/–7.9 (10.2)	–5.3 (15.3)/–6.1 (9.4)	–4.6 (14.5)/–5.4 (11.0)	–9.3 (11.6)/–7.7 (5.9)
2.5	–6.9 (15.0)/–7.6 (5.0)	–16.5 (12.2)/–7.7 (6.5)	–7.5 (7.5)/–10.5 (5.3)	–19.3 (6.4)/–13.4 (9.4)	–14.9 (7.8)/–12.4 (6.3)
5	–10.1 (7.4)/–8.6 (4.1)	–14.0 (9.7)/–10.7 (6.7)	–19.7 (10.9)/–11.3 (9.3)	–19.6 (11.5)/–12.9 (5.7)	–17.5 (11.5)/–17.9 (6.5)
White Patients
Amlodipine Dose, mg	Valsartan Dose, mg
	0	40	80	160	320
0	–7.0 (12.6)/–6.9 (7.4)	–12.4 (15.1)/–9.8 (8.4)	–13.8 (14.2)/–9.9 (5.9)	–15.3 (15.0)/–11.4 (7.3)	–18.0 (13.9)/–14.4 (7.5)
2.5	–13.7 (13.6)/–9.3 (7.6)	–15.7 (10.9)/–10.7 (7.1)	–18.0 (14.1)/–13.5 (6.9)	–15.6 (14.3)/–12.4 (7.5)	–18.2 (13.1)/–13.8 (7.8)
5	–15.0 (11.2)/–11.2 (6.7)	–19.7 (11.4)/–14.2 (6.3)	–19.4 (13.3)/–14.3 (7.0)	–19.6 (14.3)/–14.2 (7.5)	–23.0 (11.8)/–15.5 (6.0)
*The number of patients in each treatment group ranged from 9 to 19 in blacks and from 95 to 106 in whites.